rais lower ep
pressur custom point addit color ep beat key
take-away abc earn call spread gener drug buysid
vs sell side price remain rel constant suggest moder
deflationari price trend manufactur level buysid distributor
success pass end transact custom
 sell-sid moreov also suggest larg custom walgreen
and/or smaller custom independ drug retail success
captur greater discount point light seem acceler rx
reimburs pressur note manag indic
independ see pressur offer key servic critic surviv
big take pharmedium busi unlik return histor volum
level next coupl year expect enter consent decre quarter
provid greater clariti requir need re-open memphi
facil maintain current op prompt us lower ep see
rais beat lower pharmedium note ep
benefit pull forward compani guid
new rang manag believ unlik come
lower end rang seemingli suggest mid-point appropri
land point separ compani also expect net interest expens lower
origin anticip y/i rais ep
beat quarter adjust cadenc ep balanc year
given pull forward save trim ep
longer closur memphi pharmedium facil like larger
drag busi origin anticip shift valuat basi
lower price-to-earnings lower ep extend
pharmedium drag continu opioid litig uncertainti trim
price target base price-to-earnings ep
quarterli annual ep usd
lower usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
equal weight gain
share via largest custom walgreen
compani continu face headwind relat
pharmedium busi overhang relat
upsid case see modest multipl expans
gener price deflat come better fear
greater growth specialti market
downsid case see continu persist
gener deflat continu problem
pharmedium bring compani peer
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
growthmid singl digit mid singl digit mid singl digit oper expens growthmid singl digit growthtrack high end mid singl digit growthtrack high end mid singl digit growthdistribut servic op profit growth mid singl digit growth singl digit growth singl digit growthoth op profit growthhigh singl digit growthhigh singl digit growthhigh singl digit growthoper profit growth mid singl digit singl digit growth singl digit growthnet interest y/yer origin anticipatedadj effect tax changebrand inflationmid-singl digit inflationmid-singl digit inflationmid-singl digit inflationgener deflationsimilar tail end tail end tail end stabl nowbeliev stabl nowbeliev stabl nowshar ep ep flat barclay corp
amerisourcebergen revenu profit model
 annual revenu model mil abcabcabcabcabcabcrevenu revenueabdc drug specialti distribut global commerci servic anim growthabdc drug specialti distribut global commerci servic anim total revsabdc drug specialti distribut global commerci servic anim annual gross profit mil abcabcabcabcabcabcgross profit gross profit formula pharma distribut strateg global global commerci servic anim incom gross growthpharma distribut strateg global global commerci servic anim incom charg nmnmnmnmnmnmnmnmtotal gross gp margin press releas pharma distribut strateg global global commerci servic anim incom charg nmnmnmnmnmnmnmnmtotal gross profit annual oper profit mil abcabcabcabcabcabcoper profit ebit ebitpharma distribut strateg global global commerci servic anim incom growthpharma distribut strateg global global commerci servic anim incom charg nmnmnmnmnmnmnmnmtotal ebit ebit marginpharma distribut strateg global global commerci servic anim incom ebit barclay corp
 quarterli incom statement mil ep ep ep ep ep distribut sell oper addback check excl intang asset ens rate interest ens check ep fulli dilut share growth distribut sell per barclay corp
 annual revenu model mil abcabcabcrevenu revenueabdc drug specialti distribut global commerci servic anim growthabdc drug specialti distribut global commerci servic anim total revsabdc drug specialti distribut global commerci servic anim annual gross profit mil abcabcabcgross profit gross profit formula pharma distribut strateg global global commerci servic anim incom gross growthpharma distribut strateg global global commerci servic anim incom charg nmnmnmnmnmnmtotal gross gp margin press releas pharma distribut strateg global global commerci servic anim incom charg nmnmnmnmnmnmtotal gross profit annual oper profit mil abcabcabcoper profit ebit ebitpharma distribut strateg global global commerci servic anim incom growthpharma distribut strateg global global commerci servic anim incom charg nmnmnmnmnmnmtotal ebit ebit marginpharma distribut strateg global global commerci servic anim incom charg nmnmnmnmnmnmtotal ebit barclay corp
 annual incom statement distribut sell oper addback check excl intang asset ens rate interest ens check ep fulli dilut share growth distribut sell per barclay corp
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
